Paracetamol Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030)

The Report Covers Global Paracetamol Share & Industry Trends and It is Segmented by Dosage Form (Tablet, Capsules, Others), Application (Headache and Fever, Cold and Cough, Muscle Cramps, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Paracetamol Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030)

Paracetamol Market Size

Paracetamol Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 11.55 Billion
Market Size (2030) USD 14.33 Billion
CAGR (2025 - 2030) 4.41 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Paracetamol Market Summary

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Paracetamol Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Paracetamol Market Analysis

The Paracetamol Market size is estimated at USD 11.55 billion in 2025, and is expected to reach USD 14.33 billion by 2030, at a CAGR of 4.41% during the forecast period (2025-2030).

The COVID-19 pandemic had a significant impact on the market. Paracetamol, due to its widespread availability, was recommended by various healthcare authorities across the world, such as the NICE, the NHS, the CDC, and the MOHFW of the Government of India, for managing fever in adults and children with COVID-19. The COVID-19 pandemic initially created a high demand for OTC analgesics, such as paracetamol, which led to restrictions on the export of essential drugs by local authorities while maintaining sufficient stock in their country. However, the majority of paracetamol API was exported from India and China. Amid the COVID-19 situation, the governments of various authorities supported the local manufacturing of paracetamol, which strengthened the local market players and their competitiveness around the world. For instance, following the COVID-19 crisis, France planned to produce more medicines nationally, starting with paracetamol. In a joint statement, health minister Oliver Véran and junior economy minister Agnès Pannier-Runacher stated on June 18, 2020, that the government is collaborating with French pharmaceutical companies Seqens, Upsa, and Sanofi to ensure the local manufacturing of and market for paracetamol. However, post-pandemic, the increased production of paracetamol through the local market players and initiatives to encourage availability is expected to drive the market's growth over the forecast period.

There are many factors responsible for the growth of the market. The rising prevalence of conditions like headaches, flu, etc., and the increasing demand for pain management drugs are some of the major ones. Paracetamol is widely used to treat mild to moderate pains, including headaches, menstrual periods, toothaches, backaches, osteoarthritis, and cold or flu aches. Furthermore, it is an effective antipyretic used to reduce fever. The growing burden of the indicative conditions and OTC use of the products is driving the market's growth. For instance, according to the Migraine Trust, migraine is the third most common disease in the world (behind dental caries and tension-type headaches). Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Similarly, according to the WHO's March 2022 update, it is estimated that oral diseases affect nearly 3.5 billion people, often leading to pain and discomfort. Furthermore, according to World Population Prospects 2022, the share of the global population aged 65 years or older is projected to rise from 10% in 2022 to 16 percent in 2050. By 2050, the number of persons aged 65 or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. The market is expected to witness growth as the older population is more susceptible to osteoarthritis, toothache, and other indicative diseases.

Furthermore, paracetamol is extensively used by people suffering from high temperatures and the aches and pains associated with the flu. In tropical areas, influenza occurs throughout the year. In the Northern Hemisphere, the influenza season typically starts in early fall, peaks in mid-February, and ends in the late spring of the following year. The duration and severity of influenza epidemics vary, depending on the virus subtype involved. Also, the WHO, January 2022 update, the WHO GISRS laboratories tested more than 317,198 specimens from 27th December 2021 to 9th January 2022. There were 16,862 people who tested positive for influenza viruses, of whom 10,744 (63.7%) were typed as influenza A and 6,118 (36.3%) as influenza B.

Consequently, the market for paracetamol is anticipated to develop at a significant rate throughout the forecast period as the frequency and burden of certain diseases and disorders continue to rise. Paracetamol's overdose effects, however, could slow the market's expansion.

Paracetamol Industry Overview

The paracetamol market is moderately competitive and consists of several major players. Some companies currently dominating the market are GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Geno Pharma, Biological E, CFL Pharma, Cipla, and Dr. Reddy's Labs.

Paracetamol Market Leaders

  1. GlaxoSmithKline plc

  2. Teva Pharmaceuticals USA, Inc.

  3. Sanofi

  4. Mallinckrodt Pharmaceuticals

  5. Sun Pharmaceutical Industries Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Paracetamol Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Paracetamol Market News

  • April 2022: IOL Chemicals and Pharmaceuticals started commercial production of paracetamol with an installed capacity of 1800 MTPA and backward integration of Para Amino Phenol (PAP).
  • March 2022: Paraveganio became one of the first medicinal products in the world to be registered with The Vegan Society's Vegan Trademark. The certified vegan drug contains 500mg of the proven active ingredient paracetamol.

Paracetamol Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Conditions like Headaches, Flu etc.
    • 4.2.2 Increasing Demand for Pain Management Drugs
  • 4.3 Market Restraints
    • 4.3.1 Side Effects of Overdosage of Paracetamol
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Dosage Form
    • 5.1.1 Tablet
    • 5.1.2 Capsules
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Headache and Fever
    • 5.2.2 Cold and Cough
    • 5.2.3 Muscle Cramps
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GlaxoSmithKline plc
    • 6.1.2 Mallinckrodt Pharmaceuticals
    • 6.1.3 Sanofi
    • 6.1.4 Sun Pharmaceuticals Industries ltd
    • 6.1.5 Teva Pharmaceuticals USA Inc.
    • 6.1.6 Dr. Reddy's Laboratories
    • 6.1.7 Biological E Ltd
    • 6.1.8 CFL Pharma
    • 6.1.9 Cipla
    • 6.1.10 Genesis Biotec Inc.
    • 6.1.11 Granules India
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Paracetamol Industry Segmentation

As per the scope of the report, paracetamol is the most widely used analgesic and antipyretic that relieves pain and reduces fever. The paracetamol market is segmented by Dosage Form (Tablet, Capsules, Others), Application (Headache and Fever, Cold and Cough, Muscle Cramps, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Dosage Form Tablet
Capsules
Others
By Application Headache and Fever
Cold and Cough
Muscle Cramps
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Paracetamol Market Research FAQs

How big is the Paracetamol Market?

The Paracetamol Market size is expected to reach USD 11.55 billion in 2025 and grow at a CAGR of 4.41% to reach USD 14.33 billion by 2030.

What is the current Paracetamol Market size?

In 2025, the Paracetamol Market size is expected to reach USD 11.55 billion.

Who are the key players in Paracetamol Market?

GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Sanofi, Mallinckrodt Pharmaceuticals and Sun Pharmaceutical Industries Ltd. are the major companies operating in the Paracetamol Market.

Which is the fastest growing region in Paracetamol Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Paracetamol Market?

In 2025, the North America accounts for the largest market share in Paracetamol Market.

What years does this Paracetamol Market cover, and what was the market size in 2024?

In 2024, the Paracetamol Market size was estimated at USD 11.04 billion. The report covers the Paracetamol Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Paracetamol Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Paracetamol Industry Report

The report covers the global paracetamol market, highlighting its share and industry trends. It is segmented by dosage form, including tablets and capsules, and by application, such as headache and fever, cold and cough, and muscle cramps. The geographical segmentation includes North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers detailed value estimations for these segments.

The market size and price trend are crucial aspects of this analysis, which is available as a free report PDF download. The global market is thoroughly reviewed, focusing on market share and market value. Sales data and report PDFs are also included to provide comprehensive industry insights.

The growth rate and industry analysis are pivotal in understanding market dynamics. Industry information and industry outlook are provided, with detailed industry reports and industry research highlighting market trends. The report includes industry sales, industry size, and industry statistics, giving a holistic view of the market.

Market data and market forecast are integral parts of the report, which also delves into market growth and identifies market leaders. The market outlook and market overview offer predictions and a review of market segmentation. The report example and research companies provide additional context to the market value.

In summary, this report is an essential resource for understanding the paracetamol market, offering valuable insights into its current state and future prospects.

Paracetamol Market Report Snapshots